Connect with us

Business

High vaccine use urged by Tam, Njoo to beat COVID-19, restore pre-pandemic life – MSN Canada

Published

on








© Provided by The Canadian Press


OTTAWA — Canadians will need to roll up their sleeves and get vaccinated in large numbers to finally corral COVID-19 before life can return to a semblance of its pre-pandemic state, Canada’s top public health officers said Tuesday.

Loading...

Load Error

“Widespread vaccine uptake is the best shot Canadians have in regaining some of what we’ve lost and returning to things that we cherish — things like holding family and friends closely, having community events and living our lives without the fear of contracting the disease,” said Dr. Theresa Tam, the country’s chief medical officer.

Tam and her deputy, Dr. Howard Njoo, offered that assessment one day after the Trudeau government announced the latest instalment in its plan to pre-buy tens of millions of doses of potential vaccines, signing deals with two American firms.

The newest deals will allow Canada to buy as many as 76 million doses of a vaccine candidate from Maryland-based biotech company Novavax, and up to 38 million doses of the vaccine being developed by Johnson & Johnson’s pharmaceutical company Janssen Inc.

Last month, the government signed similar deals with U.S. companies Pfizer and Moderna that would give Canada access to up to 76 million more doses.

Njoo said it is not clear what percentage of Canadians will need to get vaccinated to achieve broad immunity but “the more Canadians that take advantage, the better.”

Tam suggested that the threshold for effective immunization is a moving target because understanding the science around COVID-19 is itself a work in progress.

For regulatory purposes, she said, that level has to be continuously evaluated.

“The international consensus is that we should at least look at around the 50 per cent vaccine efficacy mark,” said Tam, adding that there simply isn’t a “yes or no” answer.

More will be known when the data from ongoing Phase 3 clinical trials become available, she said.

“It’s a matter of remaining open to the evidence and being flexible.”

Right now, there appears to be low immunity to the disease around the world, “so getting a high enough vaccine uptake is going to be quite important,” said Tam.

Njoo said a vaccine could be available sometime in 2021, perhaps as early as the spring.

“We’re very optimistic here in Canada and because there are number of vaccine candidates being evaluated,” said Njoo.

“There could be an effective and safe vaccine, perhaps in 2021. We don’t know exactly when. Perhaps in the spring, maybe a little bit later. But it’s a very good thing to stay optimistic.”

This report by The Canadian Press was first published Sept. 1, 2020.

Mike Blanchfield, The Canadian Press

Let’s block ads! (Why?)



Source link

Business

Banks moved alleged dirty money despite red flags: Reports – Aljazeera.com

Published

on


Several global banks moved large sums of allegedly illicit funds over a period of nearly two decades, despite red flags about the origins of the money, BuzzFeed and other media have reported, citing confidential documents submitted by banks to the United States government.

The series of news reports on Sunday was partly based on documents, called suspicious activity reports (SARs), filed by banks and other financial firms with the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN).

The SARs, which the reports said numbered more than 2,100, were obtained by BuzzFeed News and shared with the International Consortium of Investigative Journalists (ICIJ) and other media organisations.

In all, the ICIJ reported that the files contained information about more than $2 trillion worth of transactions between 1999 and 2017, which were flagged by internal compliance departments of financial institutions as suspicious. The SARs are in themselves not necessarily proof of wrongdoing.

Five global banks appeared most often in the documents – HSBC, JPMorgan, Deutsche Bank, Standard Chartered and Bank of New York Mellon (BNY Mellon), the ICIJ reported.

A bank has a maximum of 60 days to file SARs after the date of the initial detection of a reportable transaction, according to the Treasury Department’s Office of the Comptroller of the Currency. 

Delay in reporting

The ICIJ report said that in some cases, the banks failed to report suspect transactions until years after they had processed them.

The SARs also showed that banks often moved funds for companies that were registered in offshore havens, such as the British Virgin Islands, and did not know the ultimate owner of the account, the report said.

Among the types of transactions highlighted by the report: funds processed by JPMorgan for potentially corrupt individuals and companies in Venezuela, Ukraine and Malaysia; money from a Ponzi scheme moving through HSBC; and money linked to a Ukrainian billionaire processed by Deutsche Bank.

In a statement to Reuters news agency, HSBC said “all of the information provided by the ICIJ is historical”.

The bank said that as of 2012, “HSBC embarked on a multi-year journey to overhaul its ability to combat financial crime across more than 60 jurisdictions.”

Standard Chartered said in a statement to Reuters, “We take our responsibility to fight financial crime extremely seriously and have invested substantially in our compliance programmes.”

‘Kleptocracy tour’ highlights London money-laundering

BNY Mellon told Reuters it could not comment on specific SARs.

“We fully comply with all applicable laws and regulations, and assist authorities in the important work they do,” the bank said.

JPMorgan did not immediately respond to a request for comment but said in a statement to BuzzFeed that “thousands of employees and hundreds of millions of dollars are devoted to helping support law enforcement and national security efforts”.

Deutsche Bank said in a statement on Sunday that to the “extent that information referenced by the ICIJ is derived from SARs, it should be noted that this is information that is pro-actively identified and submitted by banks to governments pursuant to the law.”

FinCEN said in a statement on its website on September 1 that it was aware that various media outlets intended to publish a series of articles based on unlawfully disclosed SARs, as well as other documents, and said that the “unauthorized disclosure of SARs is a crime that can impact the national security of the United States”.

Representatives for the US Treasury did not immediately respond to an email for comment on Sunday.

SOURCE:
Reuters news agency

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Second AstraZeneca volunteer reportedly suffers rare neurological condition, but UK company says it’s not related to vaccine – RT

Published

on


Two people have fallen ill during the trials of AstraZeneca’s coronavirus vaccine in the UK, the company’s internal papers revealed, and a source said they had both suffered from the same serious neurological disorder. 

The company published details of the trials on Saturday, after facing criticism over the lack of transparency surrounding the testing of the much-anticipated vaccine against the virus, which has so far infected more than 30.8 million people and caused over 958,000 fatalities worldwide.

The first participant of the British trials – which are being conducted in conjunction with Oxford University – fell ill after receiving one dose of the experimental vaccine in July. 

The female volunteer was later diagnosed with transverse myelitis, a rare inflammatory disease that affects the spinal cord, causing weakness, sensory alterations, and autonomic nervous-system dysfunction. The company’s spokeswoman later told the media the volunteer had undiagnosed multiple sclerosis, and the trials resumed.




Also on rt.com
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report



The second female recipient of the vaccine suffered complications after the follow-up dose in September. AstraZeneca didn’t confirm her diagnosis, but a source told the New York Times it was also transverse myelitis. 

On September 6, trials of the drug were paused again, after the second woman felt ill, but they resumed in Britain, Brazil, India, and South Africa less than a week later. The US hasn’t yet green-lighted the continuation of the test, however. 

AstraZeneca, which has administered its vaccine to some 18,000 people worldwide, said in internal documents that the two cases of the illness were “unlikely to be associated with the vaccine, or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.” 

Transverse myelitis is a serious and rare disease, and its repeated cases among the participants of the trials may well see AstraZeneca losing its vaccine bid all together. 

AstraZeneca’s vaccine uses a monkey adenovirus that shares a gene with the Covid-19 coronavirus. It’s an untested method of vaccine development, according to Kirill Dmitriev, CEO of the Russian Direct Investment Fund that bankrolled the Russian vaccine development.




Also on rt.com
Are Western attacks on the Russian Covid-19 vaccine a corporate cold war against humanity?



Unlike AstraZeneca’s jab, Russia’s Sputnik V, the world’s first registered vaccine, uses human adenoviruses as a vector – an extensively studied approach.

Earlier this month, respected British medical journal The Lancet published the Russian Ministry of Health’s Sputnik V study, showing the vaccine to be 100 percent effective, producing antibodies in all 76 participants of early-stage trials.

Think your friends would be interested? Share this story!

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Tesla Driver Caught Going 100 MPH While Fast Asleep – CarBuzz

Published

on


“Nobody was looking out the windshield to see where the car was going,” RCMP Sgt. Darrin Turnbull told CBC News. “I’ve been in policing for over 23 years and the majority of that in traffic law enforcement, and I’m speechless. I’ve never, ever seen anything like this before, but of course the technology wasn’t there.”

When the officer tried to pull the Model S driver over, traffic cleared out of its lane, causing the car to automatically accelerate up to 150 kph (93 mph). Needless to say, pulling him over was an uphill battle.

Eventually, though, the officer managed to issue a ticket for speeding and suspend the driver’s license for 24 hours for fatigue. Further investigation led to the driver being charged with dangerous driving and being summoned to court in December.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending